CN107412477A - gynecological medical bacteriostatic gel - Google Patents
gynecological medical bacteriostatic gel Download PDFInfo
- Publication number
- CN107412477A CN107412477A CN201710824899.2A CN201710824899A CN107412477A CN 107412477 A CN107412477 A CN 107412477A CN 201710824899 A CN201710824899 A CN 201710824899A CN 107412477 A CN107412477 A CN 107412477A
- Authority
- CN
- China
- Prior art keywords
- equal
- content
- less
- gynecological medical
- bacteriostatic gel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Engineering & Computer Science (AREA)
- Insects & Arthropods (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a kind of gynecological medical bacteriostatic gel formula, remember by weight, the content of Cananga odorata quintessence oil is less than or equal to 0.45g more than or equal to 0.4g in per 5g gynecological medical bacteriostatic gels, the content of safflower is less than or equal to 0.2g more than or equal to 0.15g, the content of fish pelargonium is less than or equal to 0.2g more than or equal to 0.15g, the content of kuh-seng is less than or equal to 0.45g more than or equal to 0.35g, the content of Radix Angelicae Sinensis is less than or equal to 0.75g more than or equal to 0.7g, the content of propolis is less than or equal to 0.9g more than or equal to 0.85g, the content of borneol is less than or equal to 0.98g more than or equal to 0.95g, the content of polyhexamethylene guanide is less than or equal to 0.18g more than or equal to 0.15g.The gynecological medical bacteriostatic gel of the present invention has anti-inflammation and sterilization, promotes wound healing, menstruction regulating and pain relieving, reduces melancholy uneasiness that patient is brought due to slight illness and other effects, has the characteristics of good effect, multi-functional and experience effect is good.
Description
Technical field
The present invention relates to pharmaceutical technology field, in particular to a kind of gynecological medical bacteriostatic gel.
Background technology
Most of women inflammation occurs with married femle, and also has many unmarried females to suffer from vulva easily at present
Scorching, vaginitis（Vaginitis）Etc. disease.
After disease occurs, Most patients are all liked selecting drug therapy.But the gynecological medical inflammation of existing market
Medicine function is more single, can only often play a part of anti-inflammation and sterilization, but inflamed sites effectively can not be repaiied
It is multiple, recur that probability is big the later stage again, and there is stronger excitant mostly, to the formation of women privates compared with strong stimulation, bring pain
The adverse reactions such as pain.
The content of the invention
It is a primary object of the present invention to provide a kind of gynecological medical bacteriostatic gel, cured with solving gynaecology of the prior art
With inflammation treatment pharmic function it is more single the problem of.
To achieve these goals, the invention provides a kind of gynecological medical bacteriostatic gel, including Cananga odorata quintessence oil, safranine
Flower, fish pelargonium, kuh-seng, Radix Angelicae Sinensis, propolis, borneol and polyhexamethylene guanide, remember by weight, per 5g gynecological medical bacteriostatic gels according to
The content of Lenzin oil is less than or equal to 0.45g more than or equal to 0.4g, and the content of safflower is less than or equal to 0.2g more than or equal to 0.15g,
The content of fish pelargonium is less than or equal to 0.2g more than or equal to 0.15g, and the content of kuh-seng is less than or equal to 0.45g more than or equal to 0.35g, when
The content returned is less than or equal to 0.75g more than or equal to 0.7g, and the content of propolis is less than or equal to 0.9g more than or equal to 0.85g, borneol
Content is less than or equal to 0.98g more than or equal to 0.95g, and the content of polyhexamethylene guanide is less than or equal to 0.18g more than or equal to 0.15g.
Further, gynecological medical bacteriostatic gel also includes cowberry, remembers by weight, in every 5g gynecological medical bacteriostatic gels more
The content of tangerine is less than or equal to 0.35g more than or equal to 0.25g.
Further, gynecological medical bacteriostatic gel also includes the root of Dahurain angelica, remembers by weight, white in every 5g gynecological medical bacteriostatic gels
The content of the root of Dahurian angelica is less than or equal to 0.65g more than or equal to 0.55g.
Further, gynecological medical bacteriostatic gel also includes frankincense, remembers by weight, breast in every 5g gynecological medical bacteriostatic gels
Fragrant content is less than or equal to 0.35g more than or equal to 0.25g.
Apply the technical scheme of the present invention, gynecological medical bacteriostatic gel includes Cananga odorata quintessence oil, safflower, fish pelargonium, hardship
Ginseng, Radix Angelicae Sinensis, propolis, borneol and polyhexamethylene guanide, remember by weight, the content of Cananga odorata quintessence oil in every 5g gynecological medical bacteriostatic gels
It is less than or equal to 0.45g more than or equal to 0.4g, the content of safflower is less than or equal to 0.2g, the content of fish pelargonium more than or equal to 0.15g
It is less than or equal to 0.2g more than or equal to 0.15g, the content of kuh-seng is less than or equal to 0.45g more than or equal to 0.35g, and the content of Radix Angelicae Sinensis is more than
It is less than or equal to 0.75g equal to 0.7g, the content of propolis is less than or equal to 0.9g more than or equal to 0.85g, and the content of borneol is more than or equal to
0.95g is less than or equal to 0.98g, and the content of polyhexamethylene guanide is less than or equal to 0.18g more than or equal to 0.15g.Wherein, fish pelargonium,
Kuh-seng, propolis, borneol and polyhexamethylene guanide have the effect of anti-inflammation and sterilization, and bactericidal antiphlogistic is carried out to affected part after external application；Yilan
Essential oil can cover the peculiar smell of the gynecological medical bacteriostatic gel of the present invention, increase its fragrance so that user is in a cheerful frame of mind, and reduces
The melancholy of user is uneasy；Safflower can reduce the pain that patient is brought due to inflammation, germ, reduce the melancholy of user
It is uneasy；Radix Angelicae Sinensis can benefiting blood and regulating blood circulation, menstruction regulating and pain relieving；Propolis can moisturizing myogenic, anti-inflammatory analgetic, and affected part can also be promoted to be cured
Close；Borneol can increase the body-sensing of the gynecological medical bacteriostatic gel of the present invention, bring the refreshing effect of ice, thus the gynaecology of the present invention
Medical bacteriostatic gel has anti-inflammation and sterilization, promotes wound healing, menstruction regulating and pain relieving, reduces patient because the melancholy that slight illness is brought is uneasy
And other effects, product has the refreshing experience effect of strong fragrance and ice, is used suitable for women, have good effect, it is multi-functional and
The characteristics of experience effect is good.
Embodiment
It should be noted that in the case where not conflicting, the feature in embodiment and embodiment in the application can phase
Mutually combination.
It is noted that described further below is all exemplary, it is intended to provides further instruction to the application.It is unless another
Indicate, all technologies used herein and scientific terminology are with usual with the application person of an ordinary skill in the technical field
The identical meanings of understanding.
To solve the problems, such as that gynecological medical inflammation treatment pharmic function of the prior art is more single, the invention provides
A kind of gynecological medical bacteriostatic gel.
Embodiment 1
Gynecological medical bacteriostatic gel includes Cananga odorata quintessence oil, safflower, fish pelargonium, kuh-seng, Radix Angelicae Sinensis, propolis, borneol and poly- six methylene
Base guanidine, remembers by weight, and the content of Cananga odorata quintessence oil is less than or equal to 0.45g more than or equal to 0.4g in every 5g gynecological medical bacteriostatic gels,
The content of safflower is less than or equal to 0.2g more than or equal to 0.15g, and the content of fish pelargonium is less than or equal to 0.2g more than or equal to 0.15g,
The content of kuh-seng is less than or equal to 0.45g more than or equal to 0.35g, and the content of Radix Angelicae Sinensis is less than or equal to 0.75g, propolis more than or equal to 0.7g
Content be less than or equal to 0.9g more than or equal to 0.85g, the content of borneol is less than or equal to 0.98g, poly- six methylene more than or equal to 0.95g
The content of base guanidine is less than or equal to 0.18g more than or equal to 0.15g.
Wherein, fish pelargonium, kuh-seng, propolis, borneol and polyhexamethylene guanide have the effect of anti-inflammation and sterilization, to suffering from after external application
Place carries out bactericidal antiphlogistic；Cananga odorata quintessence oil can cover the peculiar smell of the gynecological medical bacteriostatic gel of the present invention, increase its fragrance so that
User is in a cheerful frame of mind, and the melancholy for reducing user is uneasy；Safflower can reduce the pain that patient is brought due to inflammation, germ
Sense, the melancholy for reducing user are uneasy；Radix Angelicae Sinensis can benefiting blood and regulating blood circulation, menstruction regulating and pain relieving；Propolis can moisturizing myogenic, anti-inflammatory analgetic,
And affected part can also be promoted to heal；Borneol can increase the body-sensing of the gynecological medical bacteriostatic gel of the present invention, bring what ice was felt well
Effect, thus the gynecological medical bacteriostatic gel of the present invention has anti-inflammation and sterilization, promotes wound healing, menstruction regulating and pain relieving, reduces patient
Melancholy uneasiness brought due to slight illness and other effects, product have the experience effect that strong fragrance and ice are felt well, and being used in women makes
With having good effect, the characteristics of multi-functional and experience effect is good.
Embodiment 2
On the basis of embodiment 1, gynecological medical bacteriostatic gel also includes cowberry, remembers by weight, antibacterial solidifying per 5g gynecological medicals
The content of cowberry is less than or equal to 0.35g more than or equal to 0.25g in glue.Cowberry has diuresis, removing toxic substances and other effects, can treat urethra
Inflammation, addition cowberry can further increase the anti-inflammatory effects of the gynecological medical bacteriostatic gel of the present invention.
Embodiment 3
On the basis of embodiment 2, gynecological medical bacteriostatic gel also includes the root of Dahurain angelica, remembers by weight, antibacterial solidifying per 5g gynecological medicals
The content of the root of Dahurain angelica is less than or equal to 0.65g more than or equal to 0.55g in glue.The root of Dahurain angelica gets rid of illness dehumidifying, apocenosis myogenic, promoting blood circulation and stopping pain
Etc. function, the addition root of Dahurain angelica can increase the effect of the diseases such as the gynecological medical bacteriostatic gel treatment vaginitis of the present invention, promote wound
Mouth recovers.
Embodiment 4
On the basis of embodiment 3, gynecological medical bacteriostatic gel also includes frankincense, remembers by weight, antibacterial solidifying per 5g gynecological medicals
The content of frankincense is less than or equal to 0.35g more than or equal to 0.25g in glue.Frankincense has the effect of blood-activating and qi-promoting analgesic, detumescence and promoting granulation,
Addition frankincense can increase the effect of the diseases such as the gynecological medical bacteriostatic gel treatment vaginitis of the present invention, promote wound to recover.
It should be noted that term used herein above is merely to describe embodiment, and be not intended to restricted root
According to the illustrative embodiments of the application.As used herein, unless the context clearly indicates otherwise, otherwise singulative
It is also intended to include plural form, additionally, it should be understood that, when in this manual using term "comprising" and/or " bag
Include " when, it indicates existing characteristics, step, work, device, component and/or combinations thereof.
It should be noted that the term " comprising " and " having " of the description and claims of this application and they
Any deformation, it is intended that cover it is non-exclusive include, for example, containing the process of series of steps or unit, method, being
System, product or equipment are not necessarily limited to those steps or the unit clearly listed, but may include not list clearly or
For the intrinsic other steps of these processes, method, product or equipment or unit.
The preferred embodiments of the present invention are the foregoing is only, are not intended to limit the invention, for the skill of this area
For art personnel, the present invention can have various modifications and variations.Within the spirit and principles of the invention, that is made any repaiies
Change, equivalent substitution, improvement etc., should be included in the scope of the protection.
Claims (4)
1. a kind of gynecological medical bacteriostatic gel, it is characterised in that including Cananga odorata quintessence oil, safflower, fish pelargonium, kuh-seng, Radix Angelicae Sinensis, honeybee
Glue, borneol and polyhexamethylene guanide, remember by weight, and the content of Cananga odorata quintessence oil is big described in gynecological medical bacteriostatic gel described in per 5g
In being less than or equal to 0.45g equal to 0.4g, the content of the safflower is less than or equal to 0.2g, the fish pelargonium more than or equal to 0.15g
Content be less than or equal to 0.2g more than or equal to 0.15g, the content of the kuh-seng is less than or equal to 0.45g more than or equal to 0.35g, described
The content of Radix Angelicae Sinensis is less than or equal to 0.75g more than or equal to 0.7g, and the content of the propolis is less than or equal to 0.9g more than or equal to 0.85g,
The content of the borneol is less than or equal to 0.98g more than or equal to 0.95g, and the content of the polyhexamethylene guanide is more than or equal to 0.15g
Less than or equal to 0.18g.
2. gynecological medical bacteriostatic gel according to claim 1, it is characterised in that the gynecological medical bacteriostatic gel also wraps
Cowberry is included, is remembered by weight, the content of cowberry is less than or equal to more than or equal to 0.25g described in gynecological medical bacteriostatic gel described in per 5g
0.35g。
3. gynecological medical bacteriostatic gel according to claim 2, it is characterised in that the gynecological medical bacteriostatic gel also wraps
The root of Dahurain angelica is included, is remembered by weight, the content of the root of Dahurain angelica is less than or equal to more than or equal to 0.55g described in gynecological medical bacteriostatic gel described in per 5g
0.65g。
4. gynecological medical bacteriostatic gel according to claim 3, it is characterised in that the gynecological medical bacteriostatic gel also wraps
Frankincense is included, is remembered by weight, the content of frankincense is less than or equal to more than or equal to 0.25g described in gynecological medical bacteriostatic gel described in per 5g
0.35g。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710824899.2A CN107412477A (en) | 2017-09-14 | 2017-09-14 | gynecological medical bacteriostatic gel |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710824899.2A CN107412477A (en) | 2017-09-14 | 2017-09-14 | gynecological medical bacteriostatic gel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107412477A true CN107412477A (en) | 2017-12-01 |
Family
ID=60432929
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710824899.2A Pending CN107412477A (en) | 2017-09-14 | 2017-09-14 | gynecological medical bacteriostatic gel |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107412477A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107952059A (en) * | 2017-12-21 | 2018-04-24 | 广州赛美药业有限公司 | A kind of gynaecology's bacteriostatic gel and preparation method thereof |
| CN110585418A (en) * | 2018-06-13 | 2019-12-20 | 广州合伊美生物科技有限公司 | External use disinfection essential oil emulsion for women and production process thereof |
| CN113134066A (en) * | 2021-05-07 | 2021-07-20 | 诸暨市博美生物科技有限公司 | Preparation method of gynecological gel |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102091189A (en) * | 2011-01-12 | 2011-06-15 | 广州女神生物科技有限公司 | Gynecological gel |
-
2017
- 2017-09-14 CN CN201710824899.2A patent/CN107412477A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102091189A (en) * | 2011-01-12 | 2011-06-15 | 广州女神生物科技有限公司 | Gynecological gel |
Non-Patent Citations (1)
| Title |
|---|
| 福盛康医药: "【昔朵依兰紧滋凝胶】女性妇科排毒消炎私护首选产品！", 《WWW.MEIPIAN.CN/7VBE4K7?FROM=TIMELINE》 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107952059A (en) * | 2017-12-21 | 2018-04-24 | 广州赛美药业有限公司 | A kind of gynaecology's bacteriostatic gel and preparation method thereof |
| CN110585418A (en) * | 2018-06-13 | 2019-12-20 | 广州合伊美生物科技有限公司 | External use disinfection essential oil emulsion for women and production process thereof |
| CN113134066A (en) * | 2021-05-07 | 2021-07-20 | 诸暨市博美生物科技有限公司 | Preparation method of gynecological gel |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107412477A (en) | gynecological medical bacteriostatic gel | |
| CN105311332A (en) | Ulcer stopping and tissue regeneration promoting powder | |
| EP3369428B1 (en) | External traditional chinese medicine preparation for diminishing inflammation, relieving pain and promoting fast healing, and preparation method therefor | |
| CN103566071B (en) | Traditional Chinese medicine composition for treating ulcer and preparation method of powder of traditional Chinese medicine composition | |
| CN102716281B (en) | Care solution for cleaning wounds after operation | |
| US11246900B2 (en) | Anti-inflammatory, analgesic and fast-healing external traditional Chinese medicine preparation and its preparation method | |
| CN103006992A (en) | External medicinal liquor for relieving swelling and pain and preparation method thereof | |
| CN108392572B (en) | Plaster for removing stasis, promoting tissue regeneration, healing sore and relieving pain and preparation method and application thereof | |
| CN105232993A (en) | Natural plant essential oil wound healing ointment and preparation method thereof | |
| CN1104896A (en) | Multifunction medicine for curing trauma | |
| Elsass | DO NOT DUPLICATE | |
| CN1331981A (en) | Medicine for treating traumatic injury and relieving pain | |
| Poduri et al. | Innovative treatment of Burn wounds with Banana Leaf Dressing: A Case report | |
| Park et al. | Chronic open infective lateral malleolus bursitis management using local rotational flap | |
| CN110448589A (en) | A kind of liniment for treating hyperplasia of prostate | |
| CN1229117C (en) | Hircus treating medicament | |
| CN106581117A (en) | Acute waist and leg sprain treating external applying traditional Chinese medicine paste | |
| CN108310004A (en) | A kind of external prescription for controlling varicose inflammation | |
| Sampaio et al. | Clinical outcome of injuries in people assisted in a stomal therapy nursing outpatient clinic in northeastern Brazil | |
| CN110123926A (en) | A kind of nursing ointment and preparation method thereof | |
| CN113952364A (en) | External anti-inflammation preparation | |
| CN101053614B (en) | Flesh and blood healing external applied anti-infectious powder and its medicine preparation | |
| Cox et al. | Case Report: The Use of Burnaid Gel [TM] on Fracture Blisters | |
| CN1480201A (en) | Formula of medication for treating bone fracture and contuse | |
| CN111840436A (en) | Traditional Chinese medicine ointment for treating animal trauma and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20171201 |